Supratentorial Neoplasms

"Supratentorial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.

Descriptor ID	D015173
MeSH Number(s)	C04.588.614.250.195.885 C10.228.140.211.885 C10.551.240.250.700
Concept/Terms	Supratentorial Neoplasms Supratentorial Neoplasms Supratentorial Tumors Supratentorial Tumor Tumor, Supratentorial Tumors, Supratentorial Neoplasms, Supratentorial Neoplasm, Supratentorial Supratentorial Neoplasm Cancer, Supratentorial Cancer, Supratentorial Cancers, Supratentorial Supratentorial Cancer Supratentorial Cancers Supratentorial Neoplasms, Malignant Malignant Supratentorial Neoplasms Malignant Supratentorial Neoplasm Neoplasm, Malignant Supratentorial Neoplasms, Malignant Supratentorial Supratentorial Neoplasm, Malignant Primary Supratentorial Neoplasms Primary Supratentorial Neoplasms Neoplasm, Primary Supratentorial Neoplasms, Primary Supratentorial Primary Supratentorial Neoplasm Supratentorial Neoplasm, Primary Supratentorial Neoplasms, Primary Benign Supratentorial Neoplasms Benign Supratentorial Neoplasms Benign Supratentorial Neoplasm Neoplasm, Benign Supratentorial Neoplasms, Benign Supratentorial Supratentorial Neoplasm, Benign Supratentorial Neoplasms, Benign

Below are MeSH descriptors whose meaning is more general than "Supratentorial Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Supratentorial Neoplasms [C04.588.614.250.195.885]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Supratentorial Neoplasms [C10.228.140.211.885]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]
Supratentorial Neoplasms [C10.551.240.250.700]

Below are MeSH descriptors whose meaning is related to "Supratentorial Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Supratentorial Neoplasms".

Supratentorial Neoplasms
Hypothalamic Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Supratentorial Neoplasms" by people in this website by year, and whether "Supratentorial Neoplasms" was a major or minor topic of these publications.

Bar chart showing 10 publications over 10 distinct years, with a maximum of 1 publications in 1996 and 1998 and 2001 and 2002 and 2004 and 2007 and 2011 and 2021 and 2022 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Total
1996	1	1
1998	1	1
2001	1	1
2002	1	1
2004	1	1
2007	1	1
2011	1	1
2021	1	1
2022	1	1
2024	1	1

Below are the most recent publications written about "Supratentorial Neoplasms" by people in Profiles.

Lee JC, Koo SC, Furtado LV, Breuer A, Eldomery MK, Bag AK, Stow P, Rose G, Larkin T, Sances R, Kleinschmidt-DeMasters BK, Bodmer JL, Willard N, Gokden M, Dahiya S, Roberts K, Bertrand KC, Moreira DC, Robinson GW, Mo JQ, Ellison DW, Orr BA. Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement. Acta Neuropathol Commun. 2024 09 03; 12(1):143.

View in: PubMed
Gupta RK, Sharma A, Sharma MC. Overview of recent advances in the classification of ependymomas in WHO CNS5 classification: Simplified approach to their integrated diagnosis. Indian J Pathol Microbiol. 2022 May; 65(Supplement):S68-S72.

View in: PubMed
Barsouk A, Baldassari MP, Khanna O, Andrews CE, Ye DY, Velagapudi L, Al Saiegh F, Hafazalla K, Cunningham E, Patel H, Malkani K, Fitchett EM, Farrell CJ, Judy KD. Glioblastoma with deep supratentorial extension is associated with a worse overall survival. J Clin Neurosci. 2021 Nov; 93:82-87.

View in: PubMed
Lawrence YR, Wang M, Dicker AP, Andrews D, Curran WJ, Michalski JM, Souhami L, Yung WK, Mehta M. Early toxicity predicts long-term survival in high-grade glioma. Br J Cancer. 2011 Apr 26; 104(9):1365-71.

View in: PubMed
Wang HC, Hertzog JH, O'Donnell HD, Walter AW. Natural progression of an unresected supratentorial ependymoma. Pediatr Neurosurg. 2008; 44(1):75-8.

View in: PubMed
Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys. 2004 Nov 01; 60(3):853-60.

View in: PubMed
Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, Tochner Z, Lustig R, Judy KD, Pruitt A, Mollman JE, Stanczak EM, Jo MY, Than TL, Phillips P. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology. 2002 Jul 09; 59(1):40-8.

View in: PubMed
Yonekawa Y, Imhof HG, Taub E, Curcic M, Kaku Y, Roth P, Wieser HG, Groscurth P. Supracerebellar transtentorial approach to posterior temporomedial structures. J Neurosurg. 2001 Feb; 94(2):339-45.

View in: PubMed
McLaughlin MP, Marcus RB, Buatti JM, McCollough WM, Mickle JP, Kedar A, Maria BL, Million RR. Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys. 1998 Mar 01; 40(4):845-50.

View in: PubMed
Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer. 1996 Apr 15; 77(8):1535-43.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement